Lv6
1720 积分 2024-06-13 加入
Glypican-3-targeted immunoPET imaging of hepatocellular carcinoma: a translational study
1个月前
已完结
Plasma GPC3 reflects tumor GPC3 expression and predicts clinical outcomes in advanced HCC treated with atezolizumab + bevacizumab
1个月前
已完结
In-situ-formed immunotherapeutic and hemostatic dual drug-loaded nanohydrogel for preventing postoperative recurrence of hepatocellular carcinoma
1个月前
已完结
NIR-II Multimodal Phototheranostics Synergized with Antigen-Specific Vaccines for Boosted Cancer Photoimmunotherapy
1个月前
已完结
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study
1个月前
已完结
Clinical utilization of testing for cell-free DNA in hepatocellular cancer
1个月前
已完结
Immunometabolic heterogeneity in hepatocellular carcinoma: transforming cold tumors into hot tumors
1个月前
已完结
Post-treatment tumor immune microenvironment and the dual role of myeloid-derived suppressor cells (MDSCs) in cancer progression and therapeutic resistance
1个月前
已关闭
Targeting Tumor-Associated Macrophages and Cancer-Associated Fibroblasts to Overcome Therapeutic Resistance in Hepatocellular Carcinoma
1个月前
已完结
Regulating HIF-2α stabilization with an intelligent switchable nanoplatform for tumor immunity reprogramming and enhanced therapy
1个月前
已完结
皖公网安备34019202002308
